cTnl/CK-MB/Myo Test Kit

BackDuration: 10 minutes

3 in1 integrated test to confirm the diagnosis of acute myocardial injury/infarction


Clinical significance of test

cTnI: It is a contractile protein that exists only in the myocardium. It is one of the three subunits of troponin complex (I, T, C), and combines with tropomyosin in the filaments of myofibrils to form actin.

CK-MB: is an isoenzyme creatine kinase, which mainly exists in the myocardium. It is one of the important markers of myocardial injury and can effectively indicate acute myocardial infarction.

MYO: Mainly present in the myocardium and skeletal muscle. When skeletal muscle and myocardium are damaged, by acute myocardial infarction, excessive exercise or muscle disease, myoglobin is released into the blood. The levels of MYO can not be used as a single diagnostic marker, but in conjunction with cTnI or CK-MB serum levels of MYO can be used to rule out, rather than indicate myocardial infarction.


Steps of operation


Clinical application

  • Contribute to the early diagnosis and risk stratification of acute coronary syndrome
  • Differential diagnosis of various causes of chest pain
  • Monitoring of myocardial injury
  • Evaluation of clinical efficacy of certain therapeutic drugs

Interpretation of results



Contact us